106 results on '"Fissell WH"'
Search Results
2. Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Cystic Fibrosis.
- Author
-
Rolsma SL, Sokolow A, Patel PC, Sokolow K, Jimenez-Truque N, Fissell WH, Ryan V, Kirkpatrick CM, Nation RL, Gu K, Teresi M, Fishbane N, Kontos M, An G, Winokur P, Landersdorfer CB, and Creech CB
- Abstract
Background: Patients with cystic fibrosis (CF) experience recurrent bacterial pulmonary exacerbations. Management of these infections is increasingly challenging due to decreased antimicrobial susceptibility to beta-lactam antibiotics. The pharmacokinetics of these agents are inadequately characterized in patients with CF., Methods: One hundred fifty-five pediatric and adult participants with CF receiving cefepime (n=82), meropenem (n=42), or piperacillin-tazobactam (n=31) were enrolled. Opportunistic blood samples were obtained during hospitalization. Population PK analysis was conducted using nonlinear mixed-effects modeling. Clinical and demographic characteristics were evaluated as potential covariates. Monte Carlo simulations were performed to evaluate probability of target attainment (PTA) for different dosing regimens., Results: Estimated creatinine clearance, and total or lean body weight, affected the pharmacokinetics of cefepime and meropenem. No covariates were identified for piperacillin and tazobactam. In the cefepime group, a 3-h infusion achieved higher PTA than a 0.5-h infusion for all participants. Estimated breakpoints (the respective minimum inhibitory concentration (MIC) up to which ≥90% of patients are predicted to reach a PK/PD target) were two- to four-fold higher in pediatric participants receiving a 3-h vs. 0.5-h infusion. In the meropenem group, increased creatinine clearance led to reduced PTA. In the piperacillin-tazobactam group, total daily dose and mode of administration were principal drivers of PTA., Conclusions: Standard dosing regimens fail to achieve specific MIC targets in patients with CF. Therefore, clinicians should incorporate local antibiograms and PK models to determine optimal dosing. Further PK optimization to account for interindividual differences could be achieved by real-time beta-lactam therapeutic drug monitoring., (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
3. An arteriovenous mock circulatory loop and accompanying bond graph model for in vitro study of peripheral intravascular bioartificial organs.
- Author
-
Moyer JC, Chivukula VK, Taheri-Tehrani P, Sandhu S, Blaha C, Fissell WH, and Roy S
- Subjects
- Animals, Swine, Silicon, Hemodynamics, Bioartificial Organs, Cardiovascular System, Arteriovenous Shunt, Surgical
- Abstract
Background: Silicon nanopore membrane-based implantable bioartificial organs are dependent on arteriovenous implantation of a mechanically robust and biocompatible hemofilter. The hemofilter acts as a low-resistance, high-flow network, with blood flow physiology similar to arteriovenous shunts commonly created for hemodialysis access. A mock circulatory loop (MCL) that mimics shunt physiology is an essential tool for refinement and durability testing of arteriovenous implantable bioartificial organs and silicon blood-interfacing membranes. We sought to develop a compact and cost-effective MCL to replicate flow conditions through an arteriovenous shunt and used data from the MCL and swine to inform a bond graph mathematical model of the physical setup., Methods: Flow physiology through bioartificial organ prototypes was obtained in the MCL and during extracorporeal attachment to swine for biologic comparison. The MCL was tested for stability overtime by measuring pressurewave variability over a 48-h period. Data obtained in vitro and extracorporeally informed creation of a bond graph model of the MCL., Results: The arteriovenous MCL was a cost-effective, portable system that reproduced flow rates and pressures consistent with a pulsatile arteriovenous shunt as measured in swine. MCL performance was stable over prolonged use, providing a cost-effective simulator for enhanced testing of peripherally implanted bioartificial organ prototypes. The corresponding bond graph model recapitulates MCL and animal physiology, offering a tool for further refinement of the MCL system., (© 2023 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
4. Patient Preference Trade-offs for Next-Generation Kidney Replacement Therapies.
- Author
-
Wilson L, Gress AF, Frassetto L, Sarathy H, Gress EA, Fissell WH, and Roy S
- Subjects
- Humans, Male, Middle Aged, Female, Aged, Risk Assessment, Choice Behavior, Adult, Renal Replacement Therapy adverse effects, Wearable Electronic Devices, Kidney Failure, Chronic therapy, Kidney Failure, Chronic mortality, Patient Preference
- Abstract
Background: Next-generation implantable and wearable KRTs may revolutionize the lives of patients undergoing dialysis by providing more frequent and/or prolonged therapy along with greater mobility compared with in-center hemodialysis. Medical device innovators would benefit from patient input to inform product design and development. Our objective was to determine key risk/benefit considerations for patients with kidney failure and test how these trade-offs could drive patient treatment choices., Methods: We developed a choice-based conjoint discrete choice instrument and surveyed 498 patients with kidney failure. The choice-based conjoint instrument consisted of nine attributes of risk and benefit pertinent across KRT modalities. Attributes were derived from literature reviews, patient/clinician interviews, and pilot testing. The risk attributes were serious infection, death within 5 years, permanent device failure, surgical requirements, and follow-up requirements. The benefit attributes were fewer diet restrictions, improved mobility, pill burden, and fatigue. We created a random, full-profile, balanced overlap design with 14 choice pairs plus five fixed tasks to test validity. We used a mixed-effects regression model with attribute levels as independent predictor variables and choice decisions as dependent variables., Results: All variables were significantly important to patient choice preferences, except follow-up requirements. For each 1% higher risk of death within 5 years, preference utility was lower by 2.22 ( β =-2.22; 95% confidence interval [CI], -2.52 to -1.91), while for each 1% higher risk of serious infection, utility was lower by 1.38 ( β =-1.46; 95% CI, -1.77 to -1.00) according to comparisons of the β coefficients. Patients were willing to trade a 1% infection risk and 0.5% risk of death to gain complete mobility and freedom from in-center hemodialysis ( β =1.46; 95% CI, 1.27 to 1.64)., Conclusions: Despite an aversion to even a 1% higher risk of death within 5 years, serious infection, and permanent device rejection, patients with kidney failure suggested that they would trade these risks for the benefit of complete mobility., (Copyright © 2023 by the American Society of Nephrology.)
- Published
- 2024
- Full Text
- View/download PDF
5. Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers.
- Author
-
Moyer J, Wilson MW, Sorrentino TA, Santandreu A, Chen C, Hu D, Kerdok A, Porock E, Wright N, Ly J, Blaha C, Frassetto LA, Fissell WH, Vartanian SM, and Roy S
- Subjects
- Humans, Swine, Animals, Creatinine, Pilot Projects, Silicon, Swine, Miniature, Dialysis Solutions, Urea, Kidneys, Artificial, Renal Insufficiency
- Abstract
Reliable models of renal failure in large animals are critical to the successful translation of the next generation of renal replacement therapies (RRT) into humans. While models exist for the induction of renal failure, none are optimized for the implantation of devices to the retroperitoneal vasculature. We successfully piloted an embolization-to-implantation protocol enabling the first implant of a silicon nanopore membrane hemodialyzer (SNMHD) in a swine renal failure model. Renal arterial embolization is a non-invasive approach to near-total nephrectomy that preserves retroperitoneal anatomy for device implants. Silicon nanopore membranes (SNM) are efficient blood-compatible membranes that enable novel approaches to RRT. Yucatan minipigs underwent staged bilateral renal arterial embolization to induce renal failure, managed by intermittent hemodialysis. A small-scale arteriovenous SNMHD prototype was implanted into the retroperitoneum. Dialysate catheters were tunneled externally for connection to a dialysate recirculation pump. SNMHD clearance was determined by intermittent sampling of recirculating dialysate. Creatinine and urea clearance through the SNMHD were 76-105 mL/min/m
2 and 140-165 mL/min/m2 , respectively, without albumin leakage. Normalized creatinine and urea clearance measured in the SNMHD may translate to a fully implantable clinical-scale device. This pilot study establishes a path toward therapeutic testing of the clinical-scale SNMHD and other implantable RRT devices.- Published
- 2023
- Full Text
- View/download PDF
6. Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.
- Author
-
Kim EJ, Chen C, Gologorsky R, Santandreu A, Torres A, Wright N, Goodin MS, Moyer J, Chui BW, Blaha C, Brakeman P, Vartanian S, Tang Q, David Humes H, Fissell WH, and Roy S
- Subjects
- Humans, Animals, Swine, Feasibility Studies, Kidney, Bioreactors, Cell- and Tissue-Based Therapy, Epithelial Cells, Silicon, Nanopores
- Abstract
The definitive treatment for end-stage renal disease is kidney transplantation, which remains limited by organ availability and post-transplant complications. Alternatively, an implantable bioartificial kidney could address both problems while enhancing the quality and length of patient life. An implantable bioartificial kidney requires a bioreactor containing renal cells to replicate key native cell functions, such as water and solute reabsorption, and metabolic and endocrinologic functions. Here, we report a proof-of-concept implantable bioreactor containing silicon nanopore membranes to offer a level of immunoprotection to human renal epithelial cells. After implantation into pigs without systemic anticoagulation or immunosuppression therapy for 7 days, we show that cells maintain >90% viability and functionality, with normal or elevated transporter gene expression and vitamin D activation. Despite implantation into a xenograft model, we find that cells exhibit minimal damage, and recipient cytokine levels are not suggestive of hyperacute rejection. These initial data confirm the potential feasibility of an implantable bioreactor for renal cell therapy utilizing silicon nanopore membranes., (© 2023. Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
7. Wearable and implantable artificial kidney devices for end-stage kidney disease treatment: Current status and review.
- Author
-
Groth T, Stegmayr BG, Ash SR, Kuchinka J, Wieringa FP, Fissell WH, and Roy S
- Subjects
- Humans, Quality of Life, Kidneys, Artificial, Kidney Failure, Chronic surgery, Renal Insufficiency, Chronic therapy, Wearable Electronic Devices
- Abstract
Background: Chronic kidney disease (CKD) is a major cause of early death worldwide. By 2030, 14.5 million people will have end-stage kidney disease (ESKD, or CKD stage 5), yet only 5.4 million will receive kidney replacement therapy (KRT) due to economic, social, and political factors. Even for those who are offered KRT by various means of dialysis, the life expectancy remains far too low., Observation: Researchers from different fields of artificial organs collaborate to overcome the challenges of creating products such as Wearable and/or Implantable Artificial Kidneys capable of providing long-term effective physiologic kidney functions such as removal of uremic toxins, electrolyte homeostasis, and fluid regulation. A focus should be to develop easily accessible, safe, and inexpensive KRT options that enable a good quality of life and will also be available for patients in less-developed regions of the world., Conclusions: Hence, it is required to discuss some of the limits and burdens of transplantation and different techniques of dialysis, including those performed at home. Furthermore, hurdles must be considered and overcome to develop wearable and implantable artificial kidney devices that can help to improve the quality of life and life expectancy of patients with CKD., (© 2022 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
8. Inhibition of Transforming Growth Factor-β Improves Primary Renal Tubule Cell Differentiation in Long-Term Culture.
- Author
-
Hunter K, Larsen JA, Love HD, Evans RC, Roy S, Zent R, Harris RC, Wilson MH, and Fissell WH
- Subjects
- Animals, Humans, Cell Differentiation, Mammals metabolism, Receptors, Transforming Growth Factor beta metabolism, Transforming Growth Factor beta1 pharmacology, Transforming Growth Factors pharmacology, Renal Insufficiency, Transforming Growth Factor beta pharmacology
- Abstract
Patient-oriented applications of cell culture include cell therapy of organ failure like chronic renal failure. Clinical deployment of a cell-based device for artificial renal replacement requires qualitative and quantitative fidelity of a cultured cell to its in vivo counterpart. Active specific apicobasal ion transport reabsorbs 90-99% of the filtered load of salt and water in the kidney. In a bioengineered kidney, tubular transport concentrates wastes and eliminates the need for hemodialysis, but renal tubule cells in culture transport little or no salt and water due to dedifferentiation that mammalian cells undergo in vitro thereby losing important cell-type specific functions. We previously identified transforming growth factor-β (TGF-β) as a signaling pathway necessary for in vitro differentiation of renal tubule cells. Inhibition of TGF-β receptor-1 led to active and inhibitable electrolyte and water transport by primary human renal tubule epithelial cells in vitro . Addition of metformin increased transport, in the context of a transient effect on 5'-AMP-activated kinase phosphorylation. These data motivated us to examine whether increased transport was an idiosyncratic effect of SB431542, probe pathways downstream of TGF-β receptors possibly responsible for the improved differentiation, evaluate whether TGF-β inhibition induced a range of differentiated tubule functions, and to explore crosstalk between the effects of SB431542 and metformin. In this study, we use multiple small-molecule inhibitors of canonical and noncanonical pathways to confirm that inhibition of canonical TGF-β signaling caused the increased apicobasal transport. Hallmarks of proximal tubule cell function, including sodium reabsorption, para-amino hippurate excretion, and glucose uptake increased with TGF-β inhibition, and the specificity of the response was shown using inhibitors of each transport protein. We did not find any evidence of crosstalk between metformin and SB431542. These data suggest that the TGF-β signaling pathway governs multiple features of differentiation in renal proximal tubule cells in vitro . Inhibition of TGF-β by pharmacologic or genome engineering approaches may be a viable approach to enhancing differentiated function of tubule cells in vitro . Impact statement Cell therapy of renal failure requires qualitative and quantitative fidelity between in vitro and in vivo phenotypes, which has been elusive. We show that control of transforming growth factor-β signaling can promote differentiation of renal tubule cells grown in artificial environments. This is a key enabling step for cell therapy of renal failure.
- Published
- 2023
- Full Text
- View/download PDF
9. Characterization of human islet function in a convection-driven intravascular bioartificial pancreas.
- Author
-
Santandreu AG, Taheri-Tehrani P, Feinberg B, Torres A, Blaha C, Shaheen R, Moyer J, Wright N, Szot GL, Fissell WH, Vartanian S, Posselt A, and Roy S
- Abstract
Clinical islet transplantation for treatment of type 1 diabetes (T1D) is limited by the shortage of pancreas donors and need for lifelong immunosuppressive therapy. A convection-driven intravascular bioartificial pancreas (iBAP) based on highly permeable, yet immunologically protective, silicon nanopore membranes (SNM) holds promise to sustain islet function without the need for immunosuppressants. Here, we investigate short-term functionality of encapsulated human islets in an iBAP prototype. Using the finite element method (FEM), we calculated predicted oxygen profiles within islet scaffolds at normalized perifusion rates of 14-200 nl/min/IEQ. The modeling showed the need for minimum in vitro and in vivo islet perifusion rates of 28 and 100 nl/min/IEQ, respectively to support metabolic insulin production requirements in the iBAP. In vitro glucose-stimulated insulin secretion (GSIS) profiles revealed a first-phase response time of <15 min and comparable insulin production rates to standard perifusion systems (~10 pg/min/IEQ) for perifusion rates of 100-200 nl/min/IEQ. An intravenous glucose tolerance test (IVGTT), performed at a perifusion rate of 100-170 nl/min/IEQ in a non-diabetic pig, demonstrated a clinically relevant C-peptide production rate (1.0-2.8 pg/min/IEQ) with a response time of <5 min., (© 2022 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.)
- Published
- 2022
- Full Text
- View/download PDF
10. Functionalizing Polyacrylamide Hydrogels for Renal Cell Culture Under Fluid Shear Stress.
- Author
-
Love H, Evans R, Hunter K, Roy S, and Fissell WH
- Subjects
- Humans, Ligands, Extracellular Matrix Proteins, Amines, Hydrogels chemistry, Cell Culture Techniques
- Abstract
A functional renal tubule bioreactor needs to reproduce the reabsorption and barrier functions of the renal tubule. Our prior work has demonstrated that primary human renal tubule cells respond favorably when cultured on substrates with elasticity similar to healthy tissue and when subjected to fluid shear stress. Polyacrylamide (PA) is widely used in industrial processes such as water purification because it is electrically neutral and chemically inert. PA is a versatile tool as the concentration and mechanical properties of the gel are easily adjusted by varying the proportions of monomer and crosslinker. Control of mechanical properties is attractive for preparing cell culture substrates with tunable stiffness, but PA's inert chemical properties require additional steps to prepare PA for cell attachment, such as chemical reactions to bind extracellular matrix proteins. Methods based on protein functionalization for cell attachment work well in the short term but fail to provide sufficient attachment to withstand the mechanical traction of fluid shear stress. In our present work, we tested the effects of subjecting primary renal tubule cells to fluid shear stress on an elastic substrate by developing a simple method of incorporating N -(3-Aminopropyl) methacrylamide hydrochloride (APMA) into PA hydrogels. Integration of APMA into the PA hydrogel formed a nondegradable elastic substrate promoting excellent long-term cell attachment despite the forces of fluid shear stress. Impact statement Cell culture on artificial materials requires the presence of ligands on the surface to which extracellular matrix receptors on the cell can bind. Simple nonspecific adsorption or covalent linkage of plasma or extracellular matrix proteins only suffices for short-term static culture. Prolonged culture may result in degradation of the original protein such that linkage is severed but new proteins secreted by the cell are blocked from adsorbing to the artificial scaffold. This results in detachment and loss of cell mass, as well as defects in monolayers. We present a simple technique to integrate amine moeities into a polyacrylamide hydrogel that resist degradation and support long-term culture.
- Published
- 2022
- Full Text
- View/download PDF
11. The Advancing American Kidney Health Initiative: The Challenge of Overcoming the Status Quo.
- Author
-
Conway PT, Gedney N, Roy S, and Fissell WH
- Subjects
- Humans, United States, Renal Dialysis, Kidney, Kidney Failure, Chronic
- Published
- 2022
- Full Text
- View/download PDF
12. A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies.
- Author
-
Corey KB, Koo G, Stone CA Jr, Kroop SF, Fissell WH, Kozlowski S, Zhou ZH, and Phillips EJ
- Subjects
- Antibodies, Humans, Immunity, RNA, Messenger, Vaccines, Synthetic, mRNA Vaccines, COVID-19 prevention & control, COVID-19 Vaccines immunology, Polyethylene Glycols
- Published
- 2022
- Full Text
- View/download PDF
13. Superporous agarose scaffolds for encapsulation of adult human islets and human stem-cell-derived β cells for intravascular bioartificial pancreas applications.
- Author
-
Shaheen R, Gurlin RE, Gologorsky R, Blaha C, Munnangi P, Santandreu A, Torres A, Carnese P, Nair GG, Szot G, Fissell WH, Hebrok M, and Roy S
- Subjects
- Adult, Diabetes Mellitus, Type 1 therapy, Glucose pharmacology, Graft vs Host Disease prevention & control, Humans, Islets of Langerhans Transplantation, Membranes, Artificial, Nanopores, Silicon, Insulin-Secreting Cells drug effects, Insulin-Secreting Cells metabolism, Islets of Langerhans drug effects, Islets of Langerhans metabolism, Pancreas, Artificial, Sepharose chemistry, Stem Cell Transplantation methods, Tissue Scaffolds
- Abstract
Type 1 diabetic patients with severe hypoglycemia unawareness have benefitted from cellular therapies, such as pancreas or islet transplantation; however, donor shortage and the need for immunosuppression limits widespread clinical application. We previously developed an intravascular bioartificial pancreas (iBAP) using silicon nanopore membranes (SNM) for immunoprotection. To ensure ample nutrient delivery, the iBAP will need a cell scaffold with high hydraulic permeability to provide mechanical support and maintain islet viability and function. Here, we examine the feasibility of superporous agarose (SPA) as a potential cell scaffold in the iBAP. SPA exhibits 66-fold greater hydraulic permeability than the SNM along with a short (<10 μm) diffusion distance to the nearest islet. SPA also supports short-term functionality of both encapsulated human islets and stem-cell-derived enriched β-clusters in a convection-based system, demonstrated by high viability (>95%) and biphasic insulin responses to dynamic glucose stimulus. These findings suggest that the SPA scaffold will not limit nutrient delivery in a convection-based bioartificial pancreas and merits continued investigation., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
14. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets.
- Author
-
Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, and Coffey RJ
- Subjects
- Alzheimer Disease pathology, Angiotensin-Converting Enzyme 2 metabolism, Biological Transport physiology, Biomarkers metabolism, COVID-19 pathology, Cardiovascular Diseases pathology, Cell Communication physiology, Cell Line, Tumor, HeLa Cells, Humans, Lactic Acid metabolism, MicroRNAs genetics, Nanoparticles classification, Neoplasms pathology, Tumor Microenvironment, Extracellular Vesicles metabolism, MicroRNAs metabolism, Nanoparticles metabolism
- Abstract
Extracellular vesicles and exomere nanoparticles are under intense investigation as sources of clinically relevant cargo. Here we report the discovery of a distinct extracellular nanoparticle, termed supermere. Supermeres are morphologically distinct from exomeres and display a markedly greater uptake in vivo compared with small extracellular vesicles and exomeres. The protein and RNA composition of supermeres differs from small extracellular vesicles and exomeres. Supermeres are highly enriched with cargo involved in multiple cancers (glycolytic enzymes, TGFBI, miR-1246, MET, GPC1 and AGO2), Alzheimer's disease (APP) and cardiovascular disease (ACE2, ACE and PCSK9). The majority of extracellular RNA is associated with supermeres rather than small extracellular vesicles and exomeres. Cancer-derived supermeres increase lactate secretion, transfer cetuximab resistance and decrease hepatic lipids and glycogen in vivo. This study identifies a distinct functional nanoparticle replete with potential circulating biomarkers and therapeutic targets for a host of human diseases., (© 2022. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
15. Reinnovating nephrology-a call to action.
- Author
-
Moghe I, Hu R, Dhungana P, Fissell WH, and Solez K
- Subjects
- COVID-19 diagnosis, COVID-19 epidemiology, COVID-19 therapy, Diffusion of Innovation, History, 20th Century, History, 21st Century, Humans, Kidney Diseases etiology, Kidney Diseases therapy, Kidney Diseases urine, Kidney Tubules cytology, Kidney Tubules pathology, Nephrology history, Nephrology methods, Pandemics, Podocytes pathology, SARS-CoV-2 isolation & purification, SARS-CoV-2 pathogenicity, Societies, Medical, Urine cytology, COVID-19 complications, Kidney Diseases diagnosis, Nephrology trends
- Published
- 2021
- Full Text
- View/download PDF
16. Metformin and Inhibition of Transforming Growth Factor-Beta Stimulate In Vitro Transport in Primary Renal Tubule Cells.
- Author
-
Love H, Evans R, Humes HD, Roy S, Zent R, Harris R, Wilson M, and Fissell WH
- Subjects
- Cells, Cultured, Humans, Kidney Tubules cytology, Metformin pharmacology, Receptor, Transforming Growth Factor-beta Type I antagonists & inhibitors, Transforming Growth Factor beta
- Abstract
Patient-oriented applications of cell culture include cell therapy of organ failure like chronic renal failure. Clinical deployment of a cell-based device for artificial renal replacement requires qualitative and quantitative fidelity of a cultured cell to its in vivo counterpart. Active specific apicobasal ion transport reabsorbs 90-99% of the filtered load of salt and water in the kidney. In a bioengineered kidney, tubular transport concentrates wastes and eliminates the need for hemodialysis, but renal tubule cells in culture transport little or no salt and water. We previously identified transforming growth factor-beta as a signaling pathway necessary for in vitro differentiation of renal tubule cells. Inhibition of TGF-β receptor-1 led to active inhabitable electrolyte and water transport by primary human renal tubule epithelial cells in vitro . Addition of metformin increased transport, in the context of a transient effect on 5' AMP-activated kinase phosphorylation. The signals that undermine in vitro differentiation are complex, but susceptible to pharmacologic intervention. This achievement overcomes a major hurdle limiting the development of a bioreactor of cultured cells for renal replacement therapy that encompasses not only endocrine and metabolic functions but also transport and excretion. Impact statement Clinical tissue engineering requires functional fidelity of the cultured cell to its in vivo counterpart, but this has been elusive in renal tissue engineering. Typically, renal tubule cells in culture have a flattened morphology and do not express key transporters essential to their function. In this study, we build on our prior work by using small molecules to modulate pathways affected by substrate elasticity. In doing so, we are able to enhance differentiation of these cells on conventional noncompliant substrates and show transport. These results are fundamentally enabling a new generation of cell-based renal therapies.
- Published
- 2020
- Full Text
- View/download PDF
17. Renal Replacement Therapy in the ICU: The Collateral of Habit.
- Author
-
Siew ED and Fissell WH
- Subjects
- Habits, Humans, Intensive Care Units, Renal Replacement Therapy, Acute Kidney Injury therapy, Respiration, Artificial
- Published
- 2020
- Full Text
- View/download PDF
18. Reconsidering Garth Robinson: fluid flow and the glomerular filtration barrier.
- Author
-
Fissell WH
- Subjects
- Animals, Basement Membrane physiology, Glomerular Filtration Rate, Humans, Podocytes physiology, Proteinuria drug therapy, Renin-Angiotensin System drug effects, Renin-Angiotensin System physiology, Glomerular Filtration Barrier physiology
- Abstract
Purpose of Review: The goal of this review is to present recent models of the filtration barrier that may suggest mechanism-based treatments for proteinuric renal disease. The vast majority of renal failure occurs in diseases of glomerular proteinuria. The physiology of the filtration barrier remains incompletely understood, preventing invention of mechanism-based therapies. Research is currently dominated by molecular biology approaches to the kidney instead of engineering-based filtration and transport models., Recent Findings: Reexamination of two older paradigms (basement membrane and slit diaphragm) and critical analysis of newer models may provide mechanistic insight to guide further research. We expand on our theory of podocyte-basement membrane mechanical interactions and speculate on mechanisms of action of the leading treatment for proteinuria, angiotensin blockade., Summary: Treatment of proteinuria remains largely empiric and based on inhibition of the renin-angiotensin-aldosterone system, with additional benefit from statins and vitamin D. Improved definition of transport phenomena in the capillary wall may suggest rational design of new interventions.
- Published
- 2020
- Full Text
- View/download PDF
19. Ambulatory Hemodialysis-Technology Landscape and Potential for Patient-Centered Treatment.
- Author
-
Hojs N, Fissell WH, and Roy S
- Subjects
- Equipment Design, Humans, Kidneys, Artificial, Renal Insufficiency, Chronic diagnosis, Renal Insufficiency, Chronic physiopathology, Treatment Outcome, Ambulatory Care, Hemodialysis, Home adverse effects, Hemodialysis, Home instrumentation, Kidney physiopathology, Patient-Centered Care, Renal Insufficiency, Chronic therapy, Self Care adverse effects, Self Care instrumentation
- Abstract
CKD is a worldwide health problem and the number of patients requiring kidney replacement therapy is rising. In the United States, most patients with ESKD rely on in-center hemodialysis, which is burdensome and does not provide the same long-term benefits as kidney transplantation. Intensive hemodialysis treatments have demonstrated improved clinical outcomes, but its wider adoption is limited by equipment complexity and patient apprehension. Ambulatory devices for hemodialysis offer the potential for self-care treatment outside the clinical setting as well as frequent and prolonged sessions. This article explains the motivation for ambulatory hemodialysis and provides an overview of the necessary features of key technologies that will be the basis for new wearable and implantable devices. Early work by pioneers of hemodialysis is described followed by recent experience using a wearable unit on patients. Finally, ongoing efforts to develop an implantable device for kidney replacement and its potential for implantable hemodialysis are presented., (Copyright © 2020 by the American Society of Nephrology.)
- Published
- 2020
- Full Text
- View/download PDF
20. Treating the kidneys - a new era in the United States (and beyond).
- Author
-
Fissell WH and Roy S
- Subjects
- Humans, United States, Health Policy, Kidney Diseases therapy, Therapies, Investigational
- Published
- 2019
- Full Text
- View/download PDF
21. Genome Engineering Renal Epithelial Cells for Enhanced Volume Transport Function.
- Author
-
Wilson MH, Veach RA, Luo W, Welch RC, Roy S, and Fissell WH
- Abstract
Introduction: Bioengineering an implantable artificial kidney (IAK) will require renal epithelial cells capable of reabsorption of salt and water. We used genome engineering to modify cells for improved Na
+ /H+ exchange and H2 O reabsorption. The non-viral piggyBac transposon system enables genome engineering cells to stably overexpress one or more transgenes simultaneously., Methods: We generated epitope-tagged human sodium hydrogen exchanger 3 (NHE3) and aquaporin-1 (AQP1) cDNA expressing piggyBac transposon vectors. Transgene expression was evaluated via western blot and immunofluorescence. Flow cytometry analysis was used to quantitate transporter expression in a library of genome engineered clones. Cell surface biotinylation was used evaluate surface protein localization. Blister formation assays were used to monitor cellular volumetric transport., Results: piggyBac enabled stable transposon integration and overexpression of cumate-inducible NHE3 and/or constitutively expressing AQP1 in cultured renal (MDCK) epithelial cells. Cell surface delivery of NHE3 and AQP1 was confirmed using cell surface biotinylation assays. Flow cytometry of a library of MDCK clones revealed varying expression of AQP1 and NHE3. MDCK cells expressing AQP1 and cumate-inducible NHE3 demonstrated increased volumetric transport., Conclusions: Our results demonstrate that renal epithelial cells an be genome engineered for enhanced volumetric transport that will be needed for an IAK device. Our results lay the foundation for future studies of genome engineering human kidney cells for renal tubule cell therapy., (© This is a U.S. government work and its text is not subject to copyright protection in the United States; however, its text may be subject to foreign copyright protection 2019.)- Published
- 2019
- Full Text
- View/download PDF
22. In vitro and in vivo hemocompatibility assessment of ultrathin sulfobetaine polymer coatings for silicon-based implants.
- Author
-
Iqbal Z, Kim S, Moyer J, Moses W, Abada E, Wright N, Kim EJ, Park J, Fissell WH, Vartanian S, and Roy S
- Subjects
- Animals, Biofouling prevention & control, Blood metabolism, Blood Coagulation drug effects, Coated Materials, Biocompatible metabolism, Female, Humans, Membranes, Artificial, Methacrylates metabolism, Models, Animal, Molecular Conformation, Nanoparticles metabolism, Platelet Adhesiveness drug effects, Porosity, Prostheses and Implants, Silicon metabolism, Surface Properties, Swine, Time Factors, Coated Materials, Biocompatible chemistry, Methacrylates chemical synthesis, Nanoparticles chemistry, Silicon chemistry
- Published
- 2019
- Full Text
- View/download PDF
23. Substrate Elasticity Governs Differentiation of Renal Tubule Cells in Prolonged Culture.
- Author
-
Love HD, Ao M, Jorgensen S, Swearingen L, Ferrell N, Evans R, Gewin L, Harris RC, Zent R, Roy S, and Fissell WH
- Subjects
- Animals, Aquaporins metabolism, Cell Proliferation drug effects, Cell Shape drug effects, Cells, Cultured, Humans, Mice, Receptors, Transforming Growth Factor beta metabolism, Signal Transduction drug effects, Sodium-Hydrogen Exchanger 3 metabolism, Transforming Growth Factor beta metabolism, Cell Differentiation drug effects, Elasticity, Hydrogels pharmacology, Kidney Tubules cytology
- Abstract
Impact Statement: Successful clinical tissue engineering requires functional fidelity of the cultured cell to its in vivo counterpart, but this has been elusive in renal tissue engineering. Typically, renal proximal tubule cells in culture have a flattened morphology and do not express key transporters essential to their function. In this article, we show for the first time that in vitro substrate mechanical properties dictate differentiation of cultured renal proximal tubule cells. Remarkably, this effect was only discernable after 4 weeks in culture, longer than usually reported for this cell type. These results demonstrate a new tunable parameter to optimize cell differentiation in renal tissue engineering.
- Published
- 2019
- Full Text
- View/download PDF
24. Reassessment of Exosome Composition.
- Author
-
Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, Liebler DC, Ping J, Liu Q, Evans R, Fissell WH, Patton JG, Rome LH, Burnette DT, and Coffey RJ
- Subjects
- Annexin A1 metabolism, Argonaute Proteins metabolism, Cell Line, Tumor, Cell Membrane metabolism, Cell-Derived Microparticles metabolism, DNA metabolism, Exosomes chemistry, Extracellular Vesicles, Female, Humans, Lysosomes metabolism, Male, Proteins metabolism, RNA metabolism, Exosomes metabolism, Exosomes physiology
- Abstract
The heterogeneity of small extracellular vesicles and presence of non-vesicular extracellular matter have led to debate about contents and functional properties of exosomes. Here, we employ high-resolution density gradient fractionation and direct immunoaffinity capture to precisely characterize the RNA, DNA, and protein constituents of exosomes and other non-vesicle material. Extracellular RNA, RNA-binding proteins, and other cellular proteins are differentially expressed in exosomes and non-vesicle compartments. Argonaute 1-4, glycolytic enzymes, and cytoskeletal proteins were not detected in exosomes. We identify annexin A1 as a specific marker for microvesicles that are shed directly from the plasma membrane. We further show that small extracellular vesicles are not vehicles of active DNA release. Instead, we propose a new model for active secretion of extracellular DNA through an autophagy- and multivesicular-endosome-dependent but exosome-independent mechanism. This study demonstrates the need for a reassessment of exosome composition and offers a framework for a clearer understanding of extracellular vesicle heterogeneity., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
25. Application of physiological shear stress to renal tubular epithelial cells.
- Author
-
Ferrell N, Sandoval RM, Molitoris BA, Brakeman P, Roy S, and Fissell WH
- Subjects
- Administration, Intravenous, Animals, Cell Membrane physiology, Cells, Cultured, Epithelial Cells cytology, Fluorescent Dyes administration & dosage, Glomerular Filtration Rate physiology, Intravital Microscopy instrumentation, Kidney Tubules, Proximal physiology, Microfluidic Analytical Techniques instrumentation, Microscopy, Fluorescence, Multiphoton instrumentation, Microscopy, Fluorescence, Multiphoton methods, Rats, Shear Strength, Epithelial Cells physiology, Intravital Microscopy methods, Kidney Tubules, Proximal cytology, Microfluidic Analytical Techniques methods, Stress, Mechanical
- Abstract
Renal tubular epithelial cells are consistently exposed to flow of glomerular filtrate that creates fluid shear stress at the apical cell surface. This biophysical stimulus regulates several critical renal epithelial cell functions, including transport, protein uptake, and barrier function. Defining the in vivo mechanical conditions in the kidney tubule is important for accurately recapitulating these conditions in vitro. Here we provide a summary of the fluid flow conditions in the kidney and how this translates into different levels of fluid shear stress down the length of the nephron. A detailed method is provided for measuring fluid flow in the proximal tubule by intravital microscopy. Devices to mimic in vivo fluid shear stress for in vitro studies are discussed, and we present two methods for culture and analysis of renal tubule epithelial cells exposed physiological levels of fluid shear stress. The first is a microfluidic device that permits application of controlled shear stress to cells cultured on porous membranes. The second is culture of renal tubule cells on an orbital shaker. Each method has advantages and disadvantages that should be considered in the context of the specific experimental objectives., (© 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
26. Beta-lactam carryover in arterial and central venous catheters is negligible.
- Author
-
Marsh E, Verhoven SM, Groszek JJ, Fissell WH, An G, Patel P, Creech B, and Shotwell M
- Subjects
- Animals, Cattle, Chromatography, High Pressure Liquid, Catheters, Indwelling, Cefepime blood, Central Venous Catheters, Meropenem blood, Piperacillin blood, Vancomycin blood
- Abstract
Background: Therapeutic drug monitoring is used for aminoglycosides and vancomycin, and has been proposed for β-lactam antibiotics. Clinical blood samples in the ICU are often obtained via an existing vascular catheter rather than fresh needle phlebotomy. If antibiotics had previously been infused through a vascular catheter then used for blood sampling, carryover of antibiotic from the infusion to the sample might result in misleading assessments of target attainment. To address this concern we conducted a series of in vitro measurements of carryover for three commonly used antibiotics., Methods: We infused piperacillin-tazobactam, meropenem, and cefepime at pharmacologic concentrations through commonly used vascular catheters at our hospital and flushed the catheters. We then aspirated warmed citrated bovine blood through each catheter and measured antibiotic concentrations in each aspirate., Results: Carryover was below the limits of detection for piperacillin-tazobactam, meropenem, and vancomycin. Cefepime carryover, in contrast, was not negligible and needs to be investigated more fully., Conclusion: Carryover from prior infusions does not appear to jeopardize measurements of piperacillin-tazobactam, meropenem, or vancomycin in commonly used vascular catheters at our institution. Caution in interpreting samples obtained for cefepime measurements appears advised until more data is available., (Copyright © 2018. Published by Elsevier B.V.)
- Published
- 2018
- Full Text
- View/download PDF
27. Orbital Shear Stress Regulates Differentiation and Barrier Function of Primary Renal Tubular Epithelial Cells.
- Author
-
Ferrell N, Cheng J, Miao S, Roy S, and Fissell WH
- Subjects
- Animals, Bioartificial Organs, Cells, Cultured, Humans, Stress, Mechanical, Cell Differentiation physiology, Epithelial Cells cytology, Kidney Tubules, Proximal cytology, Tissue Engineering methods
- Abstract
Primary cells cultured in vitro gradually lose features characteristic of the in vivo phenotype. Culture techniques that help maintain cell-specific phenotype are advantageous for development of tissue engineered and bioartificial organs. Here we evaluated the phenotype of primary human renal tubular epithelial cells subjected to fluid shear stress by culturing the cells on an orbital shaker. Transepithelial electrical resistance (TEER), cell density, and gene and protein expression of proximal tubule-specific functional markers were measured in cells subjected to orbital shear stress. Cells cultured on an orbital shaker had increased TEER, higher cell density, and enhanced tubular epithelial specific gene and protein expression. This is likely due at least in part to the mechanical stress applied to the apical surface of the cells although other factors including increased nutrient and oxygen delivery and improved mixing could also play a role. These results suggest that orbital shaker culture may be a simple approach to augmenting the differentiated phenotype of cultured renal epithelial cells.
- Published
- 2018
- Full Text
- View/download PDF
28. Innovations in Wearable and Implantable Artificial Kidneys.
- Author
-
Salani M, Roy S, and Fissell WH 4th
- Subjects
- Equipment Design, Equipment Safety, Female, Follow-Up Studies, Humans, Kidney Failure, Chronic diagnosis, Male, Prosthesis Implantation, Renal Dialysis adverse effects, Renal Dialysis methods, Risk Assessment, Severity of Illness Index, Survival Analysis, Time Factors, Treatment Outcome, Wearable Electronic Devices, Kidney Failure, Chronic mortality, Kidney Failure, Chronic therapy, Kidneys, Artificial
- Abstract
More than 2 million people worldwide receive treatment for end-stage renal disease (ESRD). Current modalities of renal replacement therapy include in-center hemodialysis, peritoneal dialysis, home hemodialysis, and kidney transplantation. Patient survival has gradually increased during the past 2 decades and efforts continue to improve mortality and quality of life for patients with ESRD. Developments in sorbent technology, nanotechnology, and cell culture techniques provide promise for new innovations in ESRD management. New modalities currently in testing include wearable (WAKs) and implantable artificial kidneys (IAKs). The automated WAK (AWAK) and WAK are devices that have undergone small trials in humans. Additional study is needed before regulatory approval, coverage decisions, and widespread clinical implementation. The IAK is a biohybrid combining artificial filters and living cells currently in preclinical testing. These portable devices reduce the need for large quantities of water and continuous electrical supply. This could lower some barriers to home dialysis, making self-care renal replacement therapy more accessible and desirable. If widely successful, these devices could reduce the need to build and staff dialysis facilities, thus lowering health care costs associated with dialysis. The potential advantages and shortcomings of the AWAK, WAK, and IAK are described here., (Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
29. A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
- Author
-
Jang SM, Gharibian KN, Lewis SJ, Fissell WH, Tolwani AJ, and Mueller BA
- Subjects
- Anti-Bacterial Agents classification, Anti-Bacterial Agents pharmacokinetics, Computer Simulation, Humans, Models, Biological, beta-Lactams pharmacokinetics, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Monte Carlo Method, Renal Dialysis veterinary, beta-Lactams administration & dosage, beta-Lactams therapeutic use
- Abstract
Cefepime, ceftazidime, and piperacillin/tazobactam are commonly used beta-lactam antibiotics in the critical care setting. For critically ill patients receiving prolonged intermittent renal replacement therapy (PIRRT), limited pharmacokinetic data are available to inform clinicians on the dosing of these agents. Monte Carlo simulations (MCS) can be used to guide drug dosing when pharmacokinetic trials are not feasible. For each antibiotic, MCS using previously published pharmacokinetic data derived from critically ill patients was used to evaluate multiple dosing regimens in 4 different prolonged intermittent renal replacement therapy effluent rates and prolonged intermittent renal replacement therapy duration combinations (4 L/h × 10 hours or 5 L/h × 8 hours in hemodialysis and hemofiltration modes). Antibiotic regimens were also modeled depending on whether drugs were administered during or well before prolonged intermittent renal replacement therapy therapy commenced. The probability of target attainment (PTA) was calculated using each antibiotic's pharmacodynamic target during the first 48 hours of therapy. Optimal doses were defined as the smallest daily dose achieving ≥90% probability of target attainment in all prolonged intermittent renal replacement therapy effluent and duration combinations. Cefepime 1 g every 6 hours following a 2 g loading dose, ceftazidime 2 g every 12 hours, and piperacillin/tazobactam 4.5 g every 6 hours attained the desired pharmacodynamic target in ≥90% of modeled prolonged intermittent renal replacement therapy patients. Alternatively, if an every 6-hours cefepime regimen is not desired, the cefepime 2 g pre-prolonged intermittent renal replacement therapy and 3 g post-prolonged intermittent renal replacement therapy regimen also met targets. For ceftazidime, 1 g every 6 hours or 3 g continuous infusion following a 2 g loading dose also met targets. These recommended doses provide simple regimens that are likely to achieve the pharmacodynamics target while yielding the least overall drug exposure, which should result in lower toxicity rates. These findings should be validated in the clinical setting., (© 2018, The American College of Clinical Pharmacology.)
- Published
- 2018
- Full Text
- View/download PDF
30. What Is the Glomerular Ultrafiltration Barrier?
- Author
-
Fissell WH and Miner JH
- Subjects
- Animals, Glomerular Filtration Rate, Humans, Models, Anatomic, Sensitivity and Specificity, Ultrafiltration, Hemofiltration, Kidney Glomerulus physiology, Nephrotic Syndrome physiopathology, Podocytes physiology
- Published
- 2018
- Full Text
- View/download PDF
31. Sterilization effects on ultrathin film polymer coatings for silicon-based implantable medical devices.
- Author
-
Iqbal Z, Moses W, Kim S, Kim EJ, Fissell WH, and Roy S
- Subjects
- Humans, Equipment and Supplies, Membranes, Artificial, Prostheses and Implants, Silicon chemistry, Sterilization methods
- Abstract
Novel biomaterials for medical device applications must be stable throughout all stages of preparation for surgery, including sterilization. There is a paucity of information on the effects of sterilization on sub-10 nm-thick polymeric surface coatings suitable for silicon-based bioartificial organs. This study explores the effect of five standard sterilization methods on three surface coatings applied to silicon: polyethylene glycol (PEG), poly(sulfobetaine methacrylate) (pSBMA), and poly (2-methacryloyloxyethyl phosphorylcholine) (pMPC). Autoclave, dry heat, hydrogen peroxide (H
2 O2 ) plasma, ethylene oxide gas (EtO), and electron beam (E-beam) treated coatings were analyzed to determine possible polymer degradation with sterilization. Poststerilization, there were significant alterations in contact angle, maximum change resulting from H2 O2 (Δ - 14°), autoclave (Δ + 15°), and dry heat (Δ + 23°) treatments for PEG, pSBMA, and pMPC, respectively. Less than 5% coating thickness change was found with autoclave and EtO on PEG-silicon, E-beam on pSBMA-silicon and EtO treatment on pMPC-silicon. H2 O2 treatment resulted in at least 30% decrease in thickness for all coatings. Enzyme-linked immunosorbent assays showed significant protein adsorption increase for pMPC-silicon following all sterilization methods. E-beam on PEG-silicon and dry-heat treatment on pSBMA-silicon exhibited maximum protein adsorption in each coating subset. Overall, the data suggest autoclave and EtO treatments are well-suited for PEG-silicon, while E-beam is best suited for pSBMA-silicon. pMPC-silicon was least impacted by EtO treatment. H2 O2 treatment had a negative effect on all three coatings. These results can be used to determine which surface modifications and sterilization processes to utilize for devices in vivo. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2327-2336, 2018., (© 2017 Wiley Periodicals, Inc.)- Published
- 2018
- Full Text
- View/download PDF
32. Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
- Author
-
Verhoven SM, Groszek JJ, Fissell WH, Seegmiller A, Colby J, Patel P, Verstraete A, and Shotwell M
- Subjects
- Blood Specimen Collection, Chromatography, Reverse-Phase, Drug Monitoring economics, Humans, Penicillanic Acid analysis, Penicillanic Acid pharmacokinetics, Piperacillin pharmacokinetics, Piperacillin, Tazobactam Drug Combination, Sepsis drug therapy, Tazobactam, Chromatography, High Pressure Liquid methods, Drug Monitoring methods, Penicillanic Acid analogs & derivatives, Piperacillin analysis
- Abstract
Background: Sepsis is a common diagnosis in critical care with inpatient mortality rates up to 50%. Sepsis care is organized around source control, antibiotics, and supportive care. Drug disposition is deranged by changes in volume of distribution and regional blood flow, as well as multiple organ failure. Thus, assuring that each patient with sepsis attains pharmacokinetic targets is challenging. There is currently no commercially available FDA-approved assay to measure piperacillin-tazobactam, very commonly used as a beta-lactam/beta-lactamase inhibitor combination antibiotic in the intensive care unit (ICU)., Methods: Samples were prepared by ultrafiltration of plasma collected in lithium heparin Vacutainers. Separation was achieved by gradient elution on a C-18 column followed by UV detection at 214 nm. The method is validated in residual blood samples allowing investigators to exploit a waste product to develop insight into beta-lactam pharmacokinetics in the ICU., Results: Accuracy and precision were within the 25% CLIA error standard for other antibiotic assays. Free piperacillin concentrations were also in good agreement with total piperacillin concentrations measured in the same plasma by an assay in clinical use outside the United States., Conclusion: We describe a method for measuring piperacillin and tazobactam that meets clinical validation standards. Quick turnaround time and excellent accuracy on a low-cost platform make this method more than adequate for use as a routine therapeutic drug monitoring tool., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
33. A distributed solute model: an extended two-pore model with application to the glomerular sieving of Ficoll.
- Author
-
Öberg CM, Groszek JJ, Roy S, Fissell WH, and Rippe B
- Subjects
- Albumins chemistry, Albumins metabolism, Animals, Biological Transport, Computer Simulation, Ficoll chemistry, Glomerular Filtration Barrier metabolism, Membranes, Artificial, Molecular Weight, Nanopores, Permeability, Porosity, Rats, Silicones chemistry, Ficoll metabolism, Glomerular Filtration Rate, Kidney Glomerulus metabolism, Models, Biological
- Abstract
One of the many unresolved questions regarding the permeability of the glomerular filtration barrier is the reason behind the marked difference in permeability between albumin and polysaccharide probe molecules such as Ficoll and dextran of the same molecular size. Although the differences in permeability have been mainly attributed to charge effects, we have previously shown that this would require a highly charged filtration barrier, having a charge density that is ~10 times more than that on the albumin molecule. In this article, the classic two-pore model was extended by introducing size distributions on the solute molecules, making them conformationally flexible. Experimental sieving data for Ficoll from the rat glomerulus and from precision-made silicon nanopore membranes were analyzed using the model. For the rat glomerulus a small-pore radius of 36.2 Å and a geometric standard deviation (gSD) for the Ficoll size-distribution of 1.16 were obtained. For the nanopore membranes, a gSD of 1.24 and a small-pore radius of 43 Å were found. Interestingly, a variation of only ~16% in the size of the polysaccharide molecule is sufficient to explain the difference in permeability between albumin and Ficoll. Also, in line with previous data, the effects of applying a size distribution on the solute molecule are only evident when the molecular size is close to the pore size. Surely there is at least some variation in the pore radii, and, likely, the gSD obtained in the current study is an overestimation of the "true" variation in the size of the Ficoll molecule.
- Published
- 2018
- Full Text
- View/download PDF
34. Slit pores preferred over cylindrical pores for high selectivity in biomolecular filtration.
- Author
-
Feinberg BJ, Hsiao JC, Park J, Zydney AL, Fissell WH, and Roy S
- Subjects
- Animals, Cattle, Hydrophobic and Hydrophilic Interactions, Membranes, Artificial, Particle Size, Polyethylene Glycols chemistry, Porosity, Serum Albumin, Bovine chemistry, Static Electricity, Surface Properties, beta 2-Microglobulin chemistry, Filtration methods, Models, Theoretical, Nanopores, Silicon chemistry
- Abstract
Microelectromechanical systems (MEMS) have enabled the fabrication of silicon nanopore membranes (SNM) with uniform non-overlapping "slit shaped" pores. The application of SNM has been suggested for high selectivity of biomolecules in a variety of medical filtration applications. The aim of this study was to rigorously quantify the differences in sieving between slit pore SNM and more commonly modeled cylindrical pore membranes, including effects of the extended Derjaguin, Landau, Verwey, and Overbeek (XDLVO) interactions. Applying equations derived for SNM in previous work, we compare the partition coefficient of slit and cylindrical pore membranes while accounting for both steric and XDLVO interactions. Simple, steric approximations demonstrate that slit pore membranes exhibit significantly lower partition coefficients than cylindrical pore models. Incorporating XDLVO interactions results in an even more marked difference between slit pore and cylindrical pore membranes. These partition coefficients were used to evaluate changes in beta-2-microglobulin (B2M) selectivity. The data demonstrate that XDLVO interactions increase the selectivity advantage that slit pores possess over cylindrical pores, particularly for larger values of the acid-base decay constant. Finally, the bovine serum albumin (BSA) to B2M selectivity ratio was investigated. The selectivity ratio appears larger in slit pores than cylindrical pores for all cases, indicating that slit pores are particularly well suited for hemofiltration applications. The results of this study have significant implications for the application of SNM in membrane processes where highly selective separation of biomolecules is desirable., (Copyright © 2017. Published by Elsevier Inc.)
- Published
- 2018
- Full Text
- View/download PDF
35. Original article submission: Platelet stress accumulation analysis to predict thrombogenicity of an artificial kidney.
- Author
-
Buck AKW, Goebel SG, Goodin MS, Wright NJ, Groszek JJ, Moyer J, Singh S, Bluestein D, Fissell WH, and Roy S
- Subjects
- Animals, Hydrodynamics, Models, Cardiovascular, Platelet Activation, Pressure, Pulsatile Flow, Blood Platelets physiology, Computer Simulation, Kidneys, Artificial, Stress, Physiological, Thrombosis physiopathology
- Abstract
An implantable artificial kidney using a hemofilter constructed from an array of silicon membranes to provide ultrafiltration requires a suitable blood flow path to ensure stable operation in vivo. Two types of flow paths distributing blood to the array of membranes were evaluated: parallel and serpentine. Computational fluid dynamics (CFD) simulations were used to guide the development of the blood flow paths. Pressure data from animal tests were used to obtain pulsatile flow conditions imposed in the transient simulations. A key consideration for stable operation in vivo is limiting platelet stress accumulation to avoid platelet activation and thrombus formation. Platelet stress exposure was evaluated by CFD particle tracking methods through the devices to provide distributions of platelet stress accumulation. The distributions of stress accumulation over the duration of a platelet lifetime for each device revealed that stress accumulation for the serpentine flow path exceeded levels expected to cause platelet activation while the accumulated stress for the parallel flow path was below expected activation levels., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
36. Combined In Silico and In Vitro Approach Predicts Low Wall Shear Stress Regions in a Hemofilter that Correlate with Thrombus Formation In Vivo.
- Author
-
Buck AKW, Groszek JJ, Colvin DC, Keller SB, Kensinger C, Forbes R, Karp S, Williams P, Roy S, and Fissell WH
- Subjects
- Animals, Computer Simulation, Dogs, Female, Hemodynamics physiology, Hemofiltration instrumentation, Hydrodynamics, Platelet Activation, Stress, Mechanical, Equipment Design instrumentation, Kidneys, Artificial adverse effects, Thrombosis etiology, Thrombosis physiopathology
- Abstract
A major challenge in developing blood-contacting medical devices is mitigating thrombogenicity of an intravascular device. Thrombi may interfere with device function or embolize from the device to occlude distant vascular beds with catastrophic consequences. Chemical interactions between plasma proteins and bioengineered surface occur at the nanometer scale; however, continuum models of blood predict local shear stresses that lead to platelet activation or aggregation and thrombosis. Here, an iterative approach to blood flow path design incorporating in silico, in vitro, and in vivo experiments predicted the occurrence and location of thrombi in an implantable hemofilter. Low wall shear stress (WSS) regions identified by computational fluid dynamics (CFD) predicted clot formation in vivo. Revised designs based on CFD demonstrated superior performance, illustrating the importance of a multipronged approach for a successful design process.
- Published
- 2018
- Full Text
- View/download PDF
37. The bridge between transplantation and regenerative medicine: Beginning a new Banff classification of tissue engineering pathology.
- Author
-
Solez K, Fung KC, Saliba KA, Sheldon VLC, Petrosyan A, Perin L, Burdick JF, Fissell WH, Demetris AJ, and Cornell LD
- Subjects
- Graft Rejection classification, Humans, Graft Rejection pathology, Kidney pathology, Kidney Transplantation, Pathology, Clinical standards, Regenerative Medicine, Tissue Engineering
- Abstract
The science of regenerative medicine is arguably older than transplantation-the first major textbook was published in 1901-and a major regenerative medicine meeting took place in 1988, three years before the first Banff transplant pathology meeting. However, the subject of regenerative medicine/tissue engineering pathology has never received focused attention. Defining and classifying tissue engineering pathology is long overdue. In the next decades, the field of transplantation will enlarge at least tenfold, through a hybrid of tissue engineering combined with existing approaches to lessening the organ shortage. Gradually, transplantation pathologists will become tissue-(re-) engineering pathologists with enhanced skill sets to address concerns involving the use of bioengineered organs. We outline ways of categorizing abnormalities in tissue-engineered organs through traditional light microscopy or other modalities including biomarkers. We propose creating a new Banff classification of tissue engineering pathology to standardize and assess de novo bioengineered solid organs transplantable success in vivo. We recommend constructing a framework for a classification of tissue engineering pathology now with interdisciplinary consensus discussions to further develop and finalize the classification at future Banff Transplant Pathology meetings, in collaboration with the human cell atlas project. A possible nosology of pathologic abnormalities in tissue-engineered organs is suggested., (© 2017 The Authors. American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2018
- Full Text
- View/download PDF
38. Silicon nanoporous membranes as a rigorous platform for validation of biomolecular transport models.
- Author
-
Feinberg BJ, Hsiao JC, Park J, Zydney AL, Fissell WH, and Roy S
- Abstract
Microelectromechanical systems (MEMS), a technology that resulted from significant innovation in semiconductor fabrication, have recently been applied to the development of silicon nanopore membranes (SNM). In contrast to membranes fabricated from polymeric materials, SNM exhibit slit-shaped pores, monodisperse pore size, constant surface porosity, zero pore overlap, and sub-micron thickness. This development in membrane fabrication is applied herein for the validation of the XDLVO (extended Derjaguin, Landau, Verwey, and Overbeek) theory of membrane transport within the context of hemofiltration. In this work, the XDLVO model has been derived for the unique slit pore structure of SNM. Beta-2-microglobulin (B2M), a clinically relevant "middle molecular weight" solute in kidney disease, is highlighted in this study as the solute of interest. In order to determine interaction parameters within the XDLVO model for B2M and SNM, goniometric measurements were conducted, yielding a Hamaker constant of 4.61× 10
-21 J and an acid-base Gibbs free energy at contact of 41 mJ/m2 . The XDLVO model was combined with existing models for membrane sieving, with predictions of the refined model in good agreement with experimental data. Furthermore, the results show a significant difference between the XDLVO model and the simpler steric predictions typically applied in membrane transport. The refined model can be used as a tool to tailor membrane chemistry and maximize sieving or rejection of different biomolecules.- Published
- 2017
- Full Text
- View/download PDF
39. Acute Kidney Injury as a Risk Factor for Delirium and Coma during Critical Illness.
- Author
-
Siew ED, Fissell WH, Tripp CM, Blume JD, Wilson MD, Clark AJ, Vincz AJ, Ely EW, Pandharipande PP, and Girard TD
- Subjects
- Acute Kidney Injury blood, Aged, Causality, Cohort Studies, Coma blood, Comorbidity, Creatinine blood, Critical Illness epidemiology, Delirium blood, Female, Humans, Intensive Care Units, Male, Middle Aged, Prospective Studies, Respiratory Insufficiency blood, Respiratory Insufficiency epidemiology, Risk Factors, Shock blood, Shock epidemiology, Acute Kidney Injury epidemiology, Coma epidemiology, Delirium epidemiology
- Abstract
Rationale: Acute kidney injury may contribute to distant organ dysfunction. Few studies have examined kidney injury as a risk factor for delirium and coma., Objectives: To examine whether acute kidney injury is associated with delirium and coma in critically ill adults., Methods: In a prospective cohort study of intensive care unit patients with respiratory failure and/or shock, we examined the association between acute kidney injury and daily mental status using multinomial transition models adjusting for demographics, nonrenal organ failure, sepsis, prior mental status, and sedative exposure. Acute kidney injury was characterized daily using the difference between baseline and peak serum creatinine and staged according to Kidney Disease Improving Global Outcomes criteria. Mental status (normal vs. delirium vs. coma) was assessed daily with the Confusion Assessment Method for the ICU and Richmond Agitation-Sedation Scale., Measurements and Main Results: Among 466 patients, stage 2 acute kidney injury was a risk factor for delirium (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.07-2.26) and coma (OR, 2.04; 95% CI, 1.25-3.34) as was stage 3 injury (OR for delirium, 2.56; 95% CI, 1.57-4.16) (OR for coma, 3.34; 95% CI, 1.85-6.03). Daily peak serum creatinine (adjusted for baseline) values were also associated with delirium (OR, 1.35; 95% CI, 1.18-1.55) and coma (OR, 1.44; 95% CI, 1.20-1.74). Renal replacement therapy modified the association between stage 3 acute kidney injury and daily peak serum creatinine and both delirium and coma., Conclusions: Acute kidney injury is a risk factor for delirium and coma during critical illness.
- Published
- 2017
- Full Text
- View/download PDF
40. A modular microfluidic bioreactor with improved throughput for evaluation of polarized renal epithelial cells.
- Author
-
Brakeman P, Miao S, Cheng J, Lee CZ, Roy S, Fissell WH, and Ferrell N
- Abstract
Most current microfluidic cell culture systems are integrated single use devices. This can limit throughput and experimental design options, particularly for epithelial cells, which require significant time in culture to obtain a fully differentiated phenotype. In addition, epithelial cells require a porous growth substrate in order to fully polarize their distinct apical and basolateral membranes. We have developed a modular microfluidic system using commercially available porous culture inserts to evaluate polarized epithelial cells under physiologically relevant fluid flow conditions. The cell-support for the bioreactor is a commercially available microporous membrane that is ready to use in a 6-well format, allowing for cells to be seeded in advance in replicates and evaluated for polarization and barrier function prior to experimentation. The reusable modular system can be easily assembled and disassembled using these mature cells, thus improving experimental throughput and minimizing fabrication requirements. The bioreactor consists of an apical microfluidic flow path and a static basolateral chamber that is easily accessible from the outside of the device. The basolateral chamber acts as a reservoir for transport across the cell layer. We evaluated the effect of initiation of apical shear flow on short-term intracellular signaling and mRNA expression using primary human renal epithelial cells (HRECs). Ten min and 5 h after initiation of apical fluid flow over a stable monolayer of HRECs, cells demonstrated increased phosphorylation of extracellular signal-related kinase and increased expression of interleukin 6 (IL-6) mRNA, respectively. This bioreactor design provides a modular platform with rapid experimental turn-around time to study various epithelial cell functions under physiologically meaningful flow conditions.
- Published
- 2016
- Full Text
- View/download PDF
41. Introduction to Making Dialysis Adequate-Addressing its Limitations.
- Author
-
Fissell WH
- Subjects
- Humans, Kidney Failure, Chronic therapy, Renal Dialysis
- Published
- 2016
- Full Text
- View/download PDF
42. Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.
- Author
-
Shotwell MS, Nesbitt R, Madonia PN, Gould ER, Connor MJ, Salem C, Aduroja OA, Amde M, Groszek JJ, Wei P, Taylor ME, Tolwani AJ, and Fissell WH
- Subjects
- Acute Kidney Injury microbiology, Adult, Aged, Anti-Bacterial Agents blood, Anti-Bacterial Agents pharmacokinetics, Bacterial Infections complications, Critical Illness, Dialysis Solutions chemistry, Female, Hemodiafiltration, Humans, Infusions, Intravenous, Male, Middle Aged, Penicillanic Acid administration & dosage, Penicillanic Acid blood, Penicillanic Acid pharmacokinetics, Piperacillin administration & dosage, Piperacillin blood, Piperacillin pharmacokinetics, Piperacillin, Tazobactam Drug Combination, Time Factors, Acute Kidney Injury therapy, Anti-Bacterial Agents administration & dosage, Bacterial Infections drug therapy, Penicillanic Acid analogs & derivatives
- Abstract
Background and Objectives: Infection is the most common cause of death in severe AKI, but many patients receiving continuous RRT do not reach target antibiotic concentrations in plasma. Extended infusion of β-lactams is associated with improved target attainment in critically ill patients; thus, we hypothesized that extended infusion piperacillin-tazobactam would improve piperacillin target attainment compared with short infusion in patients receiving continuous RRT., Design, Setting, Participants, & Measurements: We conducted an institutional review board-approved observational cohort study of piperacillin-tazobactam pharmacokinetics and pharmacodynamics in critically ill patients receiving continuous venovenous hemodialysis and hemodiafiltration at three tertiary care hospitals between 2007 and 2015. Antibiotic concentrations in blood and/or dialysate samples were measured by liquid chromatography, and one- and two-compartment pharmacokinetic models were fitted to the data using nonlinear mixed effects regression. Target attainment for piperacillin was defined as achieving four times the minimum inhibitory concentration of 16 μg/ml for >50% of the dosing cycle. The probabilities of target attainment for a range of doses, frequencies, and infusion durations were estimated using a Monte Carlo simulation method. Target attainment was also examined as a function of patient weight and continuous RRT effluent rate., Results: Sixty-eight participants had data for analysis. Regardless of infusion duration, 6 g/d piperacillin was associated with ≤45% target attainment, whereas 12 g/d was associated with ≥95% target attainment. For 8 and 9 g/d, target attainment ranged between 68% and 85%. The probability of target attainment was lower at higher effluent rates and patient weights. For all doses, frequencies, patient weights, and continuous RRT effluent rates, extended infusion was associated with higher probability of target attainment compared with short infusion., Conclusions: Extended infusions of piperacillin-tazobactam are associated with greater probability of target attainment in patients receiving continuous RRT., (Copyright © 2016 by the American Society of Nephrology.)
- Published
- 2016
- Full Text
- View/download PDF
43. Diffusive Silicon Nanopore Membranes for Hemodialysis Applications.
- Author
-
Kim S, Feinberg B, Kant R, Chui B, Goldman K, Park J, Moses W, Blaha C, Iqbal Z, Chow C, Wright N, Fissell WH, Zydney A, and Roy S
- Subjects
- Animals, Diffusion, Humans, Kidney Failure, Chronic physiopathology, Polymers chemistry, Polymers therapeutic use, Silicon chemistry, Silicon therapeutic use, Solutions chemistry, Swine, Kidney Failure, Chronic therapy, Membranes, Artificial, Nanopores, Renal Dialysis methods
- Abstract
Hemodialysis using hollow-fiber membranes provides life-sustaining treatment for nearly 2 million patients worldwide with end stage renal disease (ESRD). However, patients on hemodialysis have worse long-term outcomes compared to kidney transplant or other chronic illnesses. Additionally, the underlying membrane technology of polymer hollow-fiber membranes has not fundamentally changed in over four decades. Therefore, we have proposed a fundamentally different approach using microelectromechanical systems (MEMS) fabrication techniques to create thin-flat sheets of silicon-based membranes for implantable or portable hemodialysis applications. The silicon nanopore membranes (SNM) have biomimetic slit-pore geometry and uniform pores size distribution that allow for exceptional permeability and selectivity. A quantitative diffusion model identified structural limits to diffusive solute transport and motivated a new microfabrication technique to create SNM with enhanced diffusive transport. We performed in vitro testing and extracorporeal testing in pigs on prototype membranes with an effective surface area of 2.52 cm2 and 2.02 cm2, respectively. The diffusive clearance was a two-fold improvement in with the new microfabrication technique and was consistent with our mathematical model. These results establish the feasibility of using SNM for hemodialysis applications with additional scale-up.
- Published
- 2016
- Full Text
- View/download PDF
44. First Implantation of Silicon Nanopore Membrane Hemofilters.
- Author
-
Kensinger C, Karp S, Kant R, Chui BW, Goldman K, Yeager T, Gould ER, Buck A, Laneve DC, Groszek JJ, Roy S, and Fissell WH
- Subjects
- Animals, Dogs, Humans, Pilot Projects, Thrombosis prevention & control, Hemofiltration instrumentation, Membranes, Artificial, Nanopores, Silicon
- Abstract
An implantable hemofilter for the treatment of kidney failure depends critically on the transport characteristics of the membrane and the biocompatibility of the membrane, cartridge, and blood conduits. A novel membrane with slit-shaped pores optimizes the trade-off between permeability and selectivity, enabling implanted therapy. Sustained (3-8) day function of an implanted parallel-plate hemofilter with minimal anticoagulation was achieved by considering biocompatibility at the subnanometer scale of chemical interactions and the millimeter scale of blood fluid dynamics. A total of 400 nm-thick polysilicon flat sheet membranes with 5-8 nm × 2 micron slit-shaped pores were surface-modified with polyethylene glycol. Hemofilter cartridge geometries were refined based on computational fluid dynamics models of blood flow. In an uncontrolled pilot study, silicon filters were implanted in six class A dogs. Cartridges were connected to the cardiovascular system by anastamoses to the aorta and inferior vena cava and filtrate was drained to collection pouches positioned in the peritoneum. Pain medicine and acetylsalicylic acid were administered twice daily until the hemofilters were harvested on postoperative days 3 (n = 2), 4 (n = 2), 5 (n = 1), and 8 (n = 1). No hemofilters were thrombosed. Animals treated for 5 and 8 days had microscopic fractures in the silicon nanopore membranes and 20-50 ml of transudative (albumin sieving coefficient θalb ~ 0.5 - 0.7) fluid in the collection pouches at the time of explant. Shorter experimental durations (3-4 days) resulted in filtration volumes similar to predictions based on mean arterial pressures and membrane hydraulic permeability and (θalb ~ 0.2 - 0.3), similar to preimplantation measurements. In conclusion, a detailed mechanistic and materials science attention to blood-material interactions allows implanted hemofilters to resist thrombosis. Additional testing is needed to determine optimal membrane characteristics and identify limiting factors in long-term implantation.
- Published
- 2016
- Full Text
- View/download PDF
45. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
- Author
-
Vijayan A, Faubel S, Askenazi DJ, Cerda J, Fissell WH, Heung M, Humphreys BD, Koyner JL, Liu KD, Mour G, Nolin TD, and Bihorac A
- Subjects
- Acute Kidney Injury epidemiology, Biomarkers urine, Clinical Trials as Topic, Decision Trees, Early Diagnosis, Humans, Acute Kidney Injury diagnosis, Acute Kidney Injury urine, Insulin-Like Growth Factor Binding Proteins urine, Risk Assessment methods, Tissue Inhibitor of Metalloproteinase-2 urine
- Abstract
Acute kidney injury (AKI) is a serious complication, commonly occurring in the critically ill population, with devastating short- and long-term consequences. Despite standardization of the definition and staging of AKI, early recognition remains challenging given that serum creatinine level is a marker, albeit imperfect, of kidney function and not kidney injury. Furthermore, the delay in increase in serum creatinine level after loss of glomerular filtration also prevents timely detection of decreased kidney function in patients with AKI. During the past decade, numerous clinical investigations have evaluated the utility of several biomarkers in the early diagnosis and risk stratification of AKI. In 2014, the US Food and Drug Administration approved the marketing of a test based on the combination of urine concentrations of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7 ([TIMP-2] × [IGFBP7]) to determine whether certain critically ill patients are at risk for developing moderate to severe AKI. The optimal role of this biomarker in the diagnosis, management, and prognosis of AKI in different clinical settings requires further clarification. In this perspective, we summarize the biological actions of these 2 cell-cycle arrest biomarkers and present important considerations regarding the clinical application, interpretation, and limitations of this novel test for the early detection of AKI., (Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
46. Preliminary Diffusive Clearance of Silicon Nanopore Membranes in a Parallel Plate Configuration for Renal Replacement Therapy.
- Author
-
Kim S, Heller J, Iqbal Z, Kant R, Kim EJ, Durack J, Saeed M, Do L, Hetts S, Wilson M, Brakeman P, Fissell WH, and Roy S
- Subjects
- Animals, Equipment Design, Nanopores, Silicon, Swine, Membranes, Artificial, Renal Dialysis instrumentation, Renal Dialysis methods
- Abstract
Silicon nanopore membranes (SNMs) with compact geometry and uniform pore size distribution have demonstrated a remarkable capacity for hemofiltration. These advantages could potentially be used for hemodialysis. Here, we present an initial evaluation of the SNM's mechanical robustness, diffusive clearance, and hemocompatibility in a parallel plate configuration. Mechanical robustness of the SNM was demonstrated by exposing membranes to high flows (200 ml/min) and pressures (1,448 mm Hg). Diffusive clearance was performed in an albumin solution and whole blood with blood and dialysate flow rates of 25 ml/min. Hemocompatibility was evaluated using scanning electron microscopy and immunohistochemistry after 4 hours in an extracorporeal porcine model. The pressure drop across the flow cell was 4.6 mm Hg at 200 ml/min. Mechanical testing showed that SNM could withstand up to 775.7 mm Hg without fracture. Urea clearance did not show an appreciable decline in blood versus albumin solution. Extracorporeal studies showed blood was successfully driven via the arterial-venous pressure differential without thrombus formation. Bare silicon showed increased cell adhesion with a 4.1-fold increase and 1.8-fold increase over polyethylene glycol (PEG)-coated surfaces for tissue plasminogen factor (t-PA) and platelet adhesion (CD41), respectively. These initial results warrant further design and development of a fully scaled SNM-based parallel plate dialyzer for renal replacement therapy.
- Published
- 2016
- Full Text
- View/download PDF
47. Optimal design of perturbations for individual two-compartment pharmacokinetic analysis.
- Author
-
Shotwell MS, Zhou M, and Fissell WH
- Subjects
- Administration, Intravenous, Anti-Bacterial Agents administration & dosage, Humans, Models, Statistical, Monte Carlo Method, Anti-Bacterial Agents pharmacokinetics, Renal Dialysis
- Abstract
We consider the optimal design of pharmacokinetic studies in patients that receive intermittent hemodialysis and intravenous antibiotic. Hemodialysis perturbs the pharmacokinetic system, providing additional opportunity for study. Designs that allocate measurements to occur exclusively during hemodialysis are shown to be viable alternatives to conventional designs, where all measurements occur outside of hemodialysis. Furthermore, hybrid designs with both conventional and intradialytic measurements have nearly double the efficiency of conventional designs. Convex optimal design and Monte Carlo techniques were used to simultaneously optimize hemodialysis event characteristics and sampling times, accounting for population pharmacokinetic heterogeneity. We also present several related methodological innovations.
- Published
- 2016
- Full Text
- View/download PDF
48. Bridging Translation by Improving Preclinical Study Design in AKI.
- Author
-
de Caestecker M, Humphreys BD, Liu KD, Fissell WH, Cerda J, Nolin TD, Askenazi D, Mour G, Harrell FE Jr, Pullen N, Okusa MD, and Faubel S
- Subjects
- Acetylcysteine therapeutic use, Acute Kidney Injury chemically induced, Animals, Contrast Media adverse effects, Disease Models, Animal, Erythropoietin therapeutic use, Free Radical Scavengers therapeutic use, Humans, Sodium Bicarbonate therapeutic use, Acute Kidney Injury prevention & control, Research Design standards, Translational Research, Biomedical standards
- Abstract
Despite extensive research, no therapeutic interventions have been shown to prevent AKI, accelerate recovery of AKI, or reduce progression of AKI to CKD in patients. This failure in translation has led investigators to speculate that the animal models being used do not predict therapeutic responses in humans. Although this issue continues to be debated, an important concern that has not been addressed is whether improvements in preclinical study design can be identified that might also increase the likelihood of translating basic AKI research into clinical practice using the current models. In this review, we have taken an evidence-based approach to identify common weaknesses in study design and reporting in preclinical AKI research that may contribute to the poor translatability of the findings. We focused on use of N-acetylcysteine or sodium bicarbonate for the prevention of contrast-induced AKI and use of erythropoietin for the prevention of AKI, two therapeutic approaches that have been extensively studied in clinical trials. On the basis of our findings, we identified five areas for improvement in preclinical study design and reporting. These suggested and preliminary guidelines may help improve the quality of preclinical research for AKI drug development., (Copyright © 2015 by the American Society of Nephrology.)
- Published
- 2015
- Full Text
- View/download PDF
49. Ciprofloxacin pharmacokinetics in critically ill patients receiving concomitant continuous venovenous hemodialysis.
- Author
-
Shotwell MS, Madonia PN, Connor MJ, Amde M, Salem C, Aduroja OA, Bauer SR, Groszek JJ, and Fissell WH
- Subjects
- Aged, Anti-Bacterial Agents blood, Anti-Bacterial Agents therapeutic use, Area Under Curve, Bacterial Infections drug therapy, Bacterial Infections mortality, Ciprofloxacin blood, Ciprofloxacin therapeutic use, Dose-Response Relationship, Drug, Drug Resistance, Microbial, Female, Humans, Male, Metabolic Clearance Rate, Microbial Sensitivity Tests, Middle Aged, Prospective Studies, Anti-Bacterial Agents pharmacokinetics, Ciprofloxacin pharmacokinetics, Critical Illness mortality, Renal Dialysis methods
- Published
- 2015
- Full Text
- View/download PDF
50. Shear stress is normalized in glomerular capillaries following ⅚ nephrectomy.
- Author
-
Ferrell N, Sandoval RM, Bian A, Campos-Bilderback SB, Molitoris BA, and Fissell WH
- Subjects
- Animals, Blood Pressure, Hematocrit, Male, Nephrectomy, Rats, Wistar, Stress, Mechanical, Capillaries physiology, Hemorheology, Kidney Glomerulus physiology, Renal Circulation, Renal Insufficiency physiopathology
- Abstract
Loss of significant functional renal mass results in compensatory structural and hemodynamic adaptations in the nephron. While these changes have been characterized in several injury models, how they affect hemodynamic forces at the glomerular capillary wall has not been adequately characterized, despite their potential physiological significance. Therefore, we used intravital multiphoton microscopy to measure the velocity of red blood cells in individual glomerular capillaries of normal rats and rats subjected to ⅚ nephrectomy. Glomerular capillary blood flow rate and wall shear stress were then estimated using previously established experimental and mathematical models to account for changes in hematocrit and blood rheology in small vessels. We found little change in the hemodynamic parameters in glomerular capillaries immediately following injury. At 2 wk postnephrectomy, significant changes in individual capillary blood flow velocity and volume flow rate were present. Despite these changes, estimated capillary wall shear stress was unchanged. This was a result of an increase in capillary diameter and changes in capillary blood rheology in nephrectomized rats.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.